Order Article Reprints

Ebner B, Apfelbeck M, Pyrgidis N, Nellessen T, Ledderose S, Pfitzinger PL, Volz Y, Berg E, Enzinger B, Rodler S, et al. Adverse Pathology after Radical Prostatectomy of Patients Eligible for Active Surveillance—A Summary 7 Years after Introducing mpMRI-Guided Biopsy in a Real-World Setting. Bioengineering. 2023; 10(2):247. https://doi.org/10.3390/bioengineering10020247

Ebner, Benedikt, Maria Apfelbeck, Nikolaos Pyrgidis, Tobias Nellessen, Stephan Ledderose, Paulo Leonardo Pfitzinger, Yannic Volz, Elena Berg, Benazir Enzinger, Severin Rodler, and et al. 2023. "Adverse Pathology after Radical Prostatectomy of Patients Eligible for Active Surveillance—A Summary 7 Years after Introducing mpMRI-Guided Biopsy in a Real-World Setting" Bioengineering 10, no. 2: 247. https://doi.org/10.3390/bioengineering10020247

Ebner, B., Apfelbeck, M., Pyrgidis, N., Nellessen, T., Ledderose, S., Pfitzinger, P. L., Volz, Y., Berg, E., Enzinger, B., Rodler, S., Atzler, M., Ivanova, T., Clevert, D.-A., Stief, C. G., & Chaloupka, M. (2023). Adverse Pathology after Radical Prostatectomy of Patients Eligible for Active Surveillance—A Summary 7 Years after Introducing mpMRI-Guided Biopsy in a Real-World Setting. Bioengineering, 10(2), 247. https://doi.org/10.3390/bioengineering10020247